Alpha & Omega Semiconductor's Omega Labs Achieves SAMHSA Accreditation for Drug Testing Innovation

Omega Laboratories Sets New Standard in Drug Testing with SAMHSA Accreditation

Omega Laboratories, Inc., a pioneering entity in drug testing solutions, recently obtains accreditation from the Substance Abuse and Mental Health Services Administration (SAMHSA) for its innovative online Custody and Control Form System (oCCF). This recognition, awarded through the National Laboratory Certification Program (NLCP), marks a significant achievement in the company's mission to streamline and enhance the drug testing process. With this accreditation, Omega solidifies its role as a vital partner for organizations involved in Federally Regulated Drug Testing Programs, enabling clients to effortlessly generate essential custody and control forms at www.occf.com.

The oCCF system stands out in the industry, being the only platform in North America to offer its services in 16 languages. This multilingual capacity demonstrates Omega's commitment to accessibility and its aim to cater to a diverse clientele. Jerry Crosby, President of Omega, highlights that the accreditation not only showcases their expertise in forensic toxicology but also emphasizes their dedication to simplifying the testing process for collectors and clinics alike. The oCCF system is versatile, supporting various types of drug testing methods, including urine, oral fluid, hair, and breath samples, as well as point-of-care testing (POCT) devices. This adaptability positions Omega as a comprehensive solution provider in an evolving industry.

Another notable feature of the oCCF system is its functionality in both Wi-Fi enabled and offline scenarios, further increasing its utility across different collection environments. This flexibility is crucial for ensuring that drug testing can occur seamlessly, regardless of technological limitations. Omega Laboratories leverages over 25 years of experience in advanced specimen analysis, making it a reliable choice for businesses seeking robust drug screening solutions. The recent SAMHSA accreditation not only reinforces Omega's reputation but also highlights its ongoing commitment to excellence and innovation within the drug testing industry.

In addition to the SAMHSA accreditation, Omega Laboratories continues to expand its technological capabilities, further enhancing its position in the market. The company's focus on integrating cutting-edge technology into its services ensures that it remains at the forefront of industry developments, consistently delivering reliable and accurate results to clients.

As Omega Laboratories advances its mission, its continued emphasis on quality and client service solidifies its standing as a leader in the drug testing sector, beneficially impacting stakeholders across various industries.